Not only circulating levels of CXCL10 but also the tissue expression was increased in various autoimmune diseases including rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, type I diabetes mellitus and autoimmune thyroid disease, [4,5,42-44]. This evidence concerns the gene CXCL10 and type 1 diabetes mellitus.